drugset / Trial / NCT00615667

Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)

NCT00615667

Phase 3 Completed 61 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

Exploring the efficacy and safety of Tacrolimus on refractory nephrotic syndrome ; Acquiring the experience of Tacrolimus on the treatment of refractory nephrotic syndrome in Chinese patients.

Timeline

Start
2006-06
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.05 mg/kg
Subject Tacrolimus Small molecule 0.1 mg/kg

Indications